Zhejiang Hongyuan

Zhejiang Hongyuan Pharmaceutical is a specialized pharmaceutical company based in Linhai, China, focusing on the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and advanced chemical intermediates. Established in 2003, the company has become a significant player in the global supply chain for cardiovascular medications, particularly the statin class of cholesterol-lowering drugs. Its primary products include intermediates and APIs for Atorvastatin, Rosuvastatin, and Pitavastatin, which are produced in GMP-compliant facilities. As a National High-tech Enterprise, Zhejiang Hongyuan leverages its expertise in complex organic synthesis to provide high-quality chemical building blocks to both domestic and international pharmaceutical partners. The company's operations are centered in the Zhejiang Provincial Chemical Medical Raw Material Base, a major hub for pharmaceutical manufacturing in China.